Načítá se...
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
INTRODUCTION: Methimazole (MMI) is the treatment of choice for patients with Graves’ disease. The major drawback of this treatment is the relapse of hyperthyroidism in half of the patients after discontinuation of the recommended conventional 12–18 months of MMI treatment. TSH receptor antibody (TRA...
Uloženo v:
| Vydáno v: | J Med Case Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8063397/ https://ncbi.nlm.nih.gov/pubmed/33888159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02788-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|